Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.78812 | 74 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.63496 | 72 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.68426 | 73 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.43175 | 77 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.81745 | 74 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.83047 | 75 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.83228 | 75 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.12365 | 76 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.63011 | 72 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.92754 | 75 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.6938 | 73 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.75865 | 73 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.68679 | 73 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.52348 | 72 |